Cenk Sumen

Dr. Sumen boasts over a decade of scientific, technological and business development expertise, with extensive time in leadership roles for Stemson Therapeutics, where he was the Chief Technology Officer and led all aspects of technology, scale-up, process development and automation, as well as Thermo Fisher Scientific and Hitachi Chemical Advanced Therapeutics Solutions. He holds a Ph.D. in Microbiology and Immunology from Stanford University, post-doctoral training at Harvard and a fellowship at the Cancer Research Institute, working at Memorial Sloan Kettering Cancer Center under Nobel Laureate Dr. Jim Allison. He is also currently an Adjunct Professor in the Department of Chemical and Biomolecular Engineering at the NYU Tandon School of Engineering.